Olivier Favre‐Bulle

Author

Olivier Favre‐Bulle

Paris Biotech Santé

Also Known As

O Favre-Bulle, O. Favre-Bulle, O. Favre‐Bulle, Olivier Favre-Bulle, Olivier Favre‐Bulle

Publications

723

Citations

H-Index

Concepts

All Affiliations

Paris Biotech Santé University of Groningen Inserm Université Paris Cité Délégation Paris 7

About

Olivier Favre‐Bulle is an author at Paris Biotech Santé specializing in biotechnology, medicine, and biochemical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	252
2	Medicine	5	5	273
3	Biochemistry	2	2	29
4	Biomolecular Engineering	2	2	29
5	Natural Sciences	1	1	18

Olivier Favre‐Bulle

Publications

619

Citations

H-Index

Page 1

	Year	Citations
Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom, Arteriosclerosis Thrombosis and Vascular Biology	2019	111
Biosynthesis of synthons in two-liquid-phase media Marcel Wubbolts, Olivier Favre‐Bulle, Bernard Witholt Biotechnology and Bioengineering	2000	104
High cell density cultivation of <i>Pseudomonas oleovorans</i>: Growth and production of poly (3‐hydroxyalkanoates) in two‐liquid phase batch and fed‐batch systems Hans Preusting, Renze van Houten, André Hoefs, Biotechnology and Bioengineering Fed‐batch SystemsBiomanufacturingEngineeringEnvironmental EngineeringTwo‐liquid Phase Batch	1993	99
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard, mAbs	2017	89
Bioconversion of N-Octane to Octanoic Acid by a Recombinant Escherichia Coli Cultured in a Two-Liquid Phase Bioreactor Olivier Favre‐Bulle, Toine Schouten, Jaap Kingma, Nature Biotechnology BiosynthesisBiomanufacturingEngineeringBiotransformationBiochemical Engineering	1991	78
Biooxidation of n-octane by a recombinant Escherichia coli in a two-liquid-phase system: Effect of medium components on cell growth and alkane oxidation activity Olivier Favre‐Bulle, Bernard Witholt Enzyme and Microbial Technology Chemical EngineeringBiomanufacturingEngineeringRecombinant Escherichia ColiBiochemical Engineering	1992	46
Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard, New Biotechnology Recombinant Antibody FragmentPharmaceutical DevelopmentCost AssessmentImmunologyBiotechnology	2018	39
Is pyrophosphate an analog of adenosine diphosphate for beef heart mitochondrial F1-ATPase. Jean‐Paul Issartel, Olivier Favre‐Bulle, Joël Lunardi, Journal of Biological Chemistry	1987	24
High Throughput Discovery of Alcohol Dehydrogenases for Industrial Biocatalysis Gilles Ravot, Denis Wahler, Olivier Favre‐Bulle, Advanced Synthesis & Catalysis EngineeringEfficient Screening ApproachIndustrial SynthesisMetabolic NetworksBioprocess Engineering	2003	18
Screening for Thermostable Esterases: From Deep Sea to Industry Gilles Ravot, D. Buteux, Olivier Favre‐Bulle, Engineering in Life Sciences BiomanufacturingEngineeringBiotransformationBiochemistryDeep Sea	2004	11

Page 1